The present study is testing spermidine treatment in elderly patients with coronary artery disease. The study is a randomized, double-blind, placebo-controlled, two-armed, parallel-group, single centre, clinical study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in left ventricular mass
Timeframe: From randomization (month 0) to 12 months
Change in appendicular lean mass and ALM index
Timeframe: From randomization (month 0) to 12 months
Change in High-sensitivity C-reactive Protein (hs-CRP)
Timeframe: From randomization (month 0) to 12 months
Change in Physical performance, peak oxygen consumption (VO2max)
Timeframe: From randomization (month 0) to 12 months